コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ent on the hypothalamic neuropeptide orexin (hypocretin).
2 attenuated the excitation of MCH neurons by hypocretin.
3 ining the neuropeptide orexin, also known as hypocretin.
4 robust direct excitation of POMC neurons by hypocretin.
5 myloid-beta, tau, total protein, YKL-40, and hypocretin.
6 neurons but showed little direct response to hypocretin.
7 beta, and not total protein, tau, YKL-40, or hypocretin.
10 that blockade of hypocretin transmission at hypocretin-1 (Hcrt-1; orexin-1) receptors decreases i.v.
15 he levels of two hypothalamic neuropeptides, hypocretin-1 and melanin-concentrating hormone, measured
21 rast, the diagnostic significance of low CSF hypocretin-1 is unclear in the presence of acute CNS inf
24 tent with a role in sleep induction, whereas hypocretin-1 levels increase at wake onset, consistent w
25 QB1*06:02 positivity (no cerebrospinal fluid hypocretin-1 results available) or narcolepsy with docum
26 nce and nuclear imaging, cerebrospinal fluid hypocretin-1, total tau, phosphorylated tau, amyloid-bet
27 hypocretin/orexin neurons is potentiated and hypocretin-1-induced action potential firing is facilita
28 signaling, MCH significantly attenuated the hypocretin-1-induced enhancement of spike frequency in h
29 Consistent with this effect, MCH attenuated hypocretin-1-induced enhancement of the frequency of min
32 suppress such attacks, the gene for orexin (hypocretin), a peptide lost in most human narcoleptics,
33 ficantly increased the synaptic responses to hypocretin, a measure of thalamocortical synapses, compa
38 gent features of neuropeptidergic functions: hypocretin and cgrp stimulated spontaneous locomotor act
40 pressure, both directly inhibit wake-active hypocretin and GABAergic cells in the lateral hypothalam
42 e neurons), synergistic direct excitation by hypocretin and presynaptic attenuation of inhibition by
43 stimulation with the excitatory neuropeptide hypocretin and the inhibitory peptide dynorphin might ex
45 pressing the peptide neurotransmitter orexin/hypocretin are ideally situated to act as a relay betwee
53 different effects on neurons postsynaptic to hypocretin axons: direct response to only one or the oth
54 n of hypothalamic microslices that contained hypocretin cells and their axons evoked dynorphin releas
55 otine withdrawal increased the percentage of hypocretin cells expressing c-Fos in the perifornical, d
56 f-administration increased the percentage of hypocretin cells expressing FosB/DeltaFosB in the latera
57 idization, we have traced the development of hypocretin cells in zebrafish from onset of expression a
60 o only one or the other of the two peptides [hypocretin cells respond to dynorphin, arcuate neuropept
62 lass of hypothalamic GI neurones, the orexin/hypocretin cells, also appear to use a non-metabolic sen
63 educed spontaneous firing of the neighboring hypocretin cells, both results consistent with reduced a
66 and suggest that the absence of hypothalamic hypocretin control on mesolimbic reward centers is cruci
67 [95% CI, 48.1%-66.3%] of 122) for narcolepsy/hypocretin deficiency (area under the curve, 0.765 [95%
68 ne optimal diagnostic cutoffs for narcolepsy/hypocretin deficiency compared with different samples: c
69 %-60.8%] of 14) for patients with narcolepsy/hypocretin deficiency vs population-based controls or al
71 ge- and sex-matched patients with narcolepsy/hypocretin deficiency were selected from 1749 patients a
72 lic encephalitis with sleepiness, cataplexy, hypocretin deficiency, and central hypothyroidism, toget
73 ss, responsible for narcolepsy-cataplexy and hypocretin deficiency, reflects a CD8+ inflammatory-medi
76 ers, with no significant differences between hypocretin-deficient and non-hypocretin-deficient patien
79 rcuate neuropeptide Y (NPY) cells respond to hypocretin], differential desensitization causing shift
80 lamic neurons producing orexins (also called hypocretins) enhance innate risk-avoidance via poorly un
84 mic structure of the zebrafish and Tetraodon hypocretin genes and the complete predicted hypocretin p
89 amic neurons expressing histamine and orexin/hypocretin (hcrt) are necessary for normal regulation of
91 oss of neurons that express the neuropeptide hypocretin (Hcrt) has been implicated in narcolepsy, a d
95 etect histamine cells in human narcoleptics, hypocretin (Hcrt) receptor-2 mutant dogs, and 3 mouse na
97 n the case of neurons expressing the peptide hypocretin (HCRT), quiescent during both non-REM and REM
98 t models of sleep/wake regulation posit that Hypocretin (Hcrt)-expressing neurons in the lateral hypo
99 s in mice, we show that neurons that produce hypocretin (Hcrt)/orexin in the lateral hypothalamic are
104 tress produced a decrement in both 5-HT- and hypocretin-induced EPSCs, an effect that was correlated
108 us, in contrast to previous suggestions that hypocretin inhibited POMC cells, our results demonstrate
109 hat glutamate and orexin (ORX, also known as hypocretin) inputs to the ventral tegmental area (VTA) d
112 n, and the hypothalamic neuropeptide orexin (hypocretin) is involved in anxiety states and arousal.
114 findings confirm recent data obtained in the hypocretin knock-out mice and suggest that the absence o
122 A, suggesting that the primary mechanism for hypocretin-mediated excitation is the activation of the
123 Y (NPY), proopiomelanocortin (POMC), orexin/hypocretin, melanin-concentrating hormone (MCH), thyrotr
126 sing progress toward integrated theories for hypocretin modulation of divergent behavioral domains.
128 al a novel and important role for the orexin/hypocretin neuronal system in reward processing and addi
130 d to overexpress the uncoupling protein 2 in hypocretin neurons (Hcrt-UCP2) have elevated hypothalami
133 by Burdakov et al. demonstrates that orexin/hypocretin neurons are inhibited by rising glucose in pa
134 t al. show that, in mice, synapses targeting hypocretin neurons become stronger when wakefulness is p
135 received direct synaptic contact from other hypocretin neurons but showed little direct response to
137 in (CREB) is also significantly increased in hypocretin neurons in cocaine-treated animals, suggestin
138 high-frequency stimulation is facilitated in hypocretin neurons in cocaine-treated mice, suggesting t
139 gonists and antagonists on identified MCH or hypocretin neurons in green fluorescent protein-expressi
140 nt potentiation of glutamatergic synapses on hypocretin neurons in mice following a cocaine-condition
143 re, the potentiation of synaptic efficacy in hypocretin neurons persists during cocaine withdrawal, b
144 crospheres was used to determine whether the hypocretin neurons project directly to the paraventricul
147 eported photostimulation of noradrenergic or hypocretin neurons that induces wake transitions from bo
151 g that long-lasting changes in synapses onto hypocretin neurons would probably be further potentiated
152 try centred on hypocretin-producing neurons (hypocretin neurons) is modified by drugs of abuse and ho
154 We studied glucose inhibition of orexin/hypocretin neurons, which promote wakefulness (their los
162 ting hypothalamic orexin (ORX: also known as hypocretin) neurons are highly sensitive to local change
164 site through which the orexin (also known as hypocretin) neurons drive arousal and promote the mainte
167 The cell bodies of neurons expressing orexin/hypocretin neuropeptides are restricted to the lateral h
169 In humans and rodents, loss of brain orexin/hypocretin (OH) neurons causes pathological sleepiness [
170 lanin-concentrating-hormone (MCH) and orexin/hypocretin (OH) neurons mediate energy accumulation and
171 neuropeptides promoting wakefulness (orexin/hypocretin; OH), or sleep (melanin-concentrating hormone
172 lamic neuropeptides, respectively called the hypocretins or orexins, which were discovered using two
173 bers of neurons that produce either orexins (hypocretins) or melanin concentrating hormone (MCH).
175 associated with HLA-DQB1*06:02 and caused by hypocretin (orexin) deficiency, is diagnosed using the M
177 the minor allele for rs7767652, upstream of hypocretin (orexin) receptor-2 (HCRTR2), were less likel
182 1 narcolepsy, a disorder caused by a lack of hypocretin (orexin), is so strongly associated with huma
188 rstood, previous studies have implicated the hypocretin/orexin (Hcrt) and nociceptin/orphanin FQ (N/O
193 g of the presynaptic marker synaptophysin in hypocretin/orexin (HCRT) neurons to determine the dynami
196 Multiple lines of evidence indicate that hypocretin/orexin (HCRT) participates in the regulation
200 racterized mammalian sleep/wake regulator is hypocretin/orexin (Hcrt), whose loss results in the slee
207 mely melanin-concentrating hormone (MCH) and hypocretin/orexin (hcrt/orx), were not detected in LHA G
209 neurotensin mRNA, but they are distinct from hypocretin/orexin and melanin-concentrating hormone (MCH
210 rs, such as the well-described neuropeptides hypocretin/orexin and melanin-concentrating hormone.
213 A report on the rapid change of activity of hypocretin/orexin cells in response to contact rather th
215 Melanin-concentrating hormone (MCH) and hypocretin/orexin neurons in the lateral hypothalamus (L
216 entiation (LTP) of glutamatergic synapses on hypocretin/orexin neurons in the lateral hypothalamus, a
217 e, the efficacy of glutamatergic synapses on hypocretin/orexin neurons is potentiated and hypocretin-
218 naptic strength at glutamatergic synapses on hypocretin/orexin neurons was also seen when mice were s
219 vation occurs in a significant number of LHA hypocretin/orexin neurons, but not CRH or MCH neurons, i
225 ting hormone and proopiomelanocortin but not hypocretin/orexin neurons; pattern B, GABAergic cortical
227 ed in part on this detailed description, the hypocretin/orexin neuropeptides have since been studied
228 ge body of literature today attests that the hypocretin/orexin neuropeptides play important roles in
229 LHA neurons also show increased CRH, but not hypocretin/orexin or MCH gene expression, as dehydration
230 Together these data implicate CRH but not hypocretin/orexin or MCH neurons in the LHA in the motor
231 Two groups of neurons in the LH, expressing hypocretin/orexin or melanin concentrating hormone (MCH)
232 H may exert a unique inhibitory influence on hypocretin/orexin signaling as a way to fine-tune the ou
233 rons in the cerebral cortex, the role of the hypocretin/orexin system in the maintenance of sleep and
236 rk controlling responses evidently come from hypocretin/orexin, but not CRH or MCH, neurons in the LH
237 -opiolemelanocortin, agouti-related peptide, hypocretin/orexin, melanin-concentrating hormone, oxytoc
239 mice expressing green fluorescent protein in hypocretin/orexin-containing neurons to examine the hypo
240 d increased the percentage of Fos-expressing hypocretin/orexin-immunoreactive neurons in these zones.
241 to examine the hypothesis that MCH modulates hypocretin/orexin-mediated effects on behavioral state a
245 munoreactive for serotonin (5-HT) and orexin/hypocretin (ORX), as well as a moderate density of fiber
248 anin-concentrating hormone (MCH), and orexin/hypocretins (ORX) produced in the hypothalamus mediate a
253 ons in EPSCs evoked by 5-HT as compared with hypocretin, possibly reflecting the different pathways a
254 at could lead to the specific elimination of hypocretin producing neurons include molecular mimicry o
255 that Hap1 is abundantly expressed in orexin (hypocretin)-producing neurons (orexin neurons), which ar
256 halamic area (LHA) orexin (OX; also known as hypocretin)-producing neurons, which control feeding, ac
257 wing studies in dogs and mice, a 95% loss of hypocretin-producing cells in postmortem hypothalami fro
258 it is not clear how the circuitry centred on hypocretin-producing neurons (hypocretin neurons) is mod
259 m and hypothalamic neurons, including orexin/hypocretin-producing neurons that regulate sleep-wake st
262 5 mg/kg/day for 14 days) pretreated with the hypocretin receptor 1 (Hcrtr-1) antagonist SB334867 (5 a
263 ceptors Drd1a and Drd2 (both downregulated), hypocretin receptor 1 (Hcrtr1), kappa opioid receptor 1
264 34867 (5 and 10 mg/kg, intraperitoneal), the hypocretin receptor 2 antagonist TCSOX229 (5 and 10 mg/k
265 eep/wake regulation, and antagonists of both hypocretin receptor type 1 (HCRTR1) and/or HCRTR2 are co
266 thetic cannabinoid agonist WIN55,212-2 using hypocretin receptor-1 (Hcrtr-1) and hypocretin receptor-
269 -2 using hypocretin receptor-1 (Hcrtr-1) and hypocretin receptor-2 antagonists and Hcrtr-1 knockout m
270 red with ketamine, whereas regulation of the hypocretin responses may contribute to the therapeutic b
271 iew current advances in the understanding of hypocretin's modulatory actions underlying conditions of
273 Narcolepsy is caused by a loss of orexin/hypocretin signaling, resulting in chronic sleepiness, f
274 is caused by a loss of orexin (also known as hypocretin) signaling, but almost nothing is known about
275 his condition is caused by a lack of orexin (hypocretin) signaling, but little is known about the neu
276 ttenuated subsequent excitatory responses to hypocretin, suggesting a long-lasting depression caused
278 enous opiates such as morphine inhibited the hypocretin system by direct actions on the cell body tha
280 We also identify an intrinsic role of the hypocretin system in energy expenditure that may not be
282 g body of evidence discerning how the orexin/hypocretin system integrates internal and external cues
283 These findings support the idea that the hypocretin system is important for behavioural changes a
286 e data are consistent with the view that the hypocretin system may be an important direct target for
287 that a deficiency in the hypothalamic orexin/hypocretin system underlies the pathogenesis of narcolep
288 the potential interrelationship between the hypocretin system, metabolism and sleep by measuring loc
290 pa-opioid receptors enhanced activity of the hypocretin system, suggesting ongoing depression by endo
291 eceptor antagonists enhanced activity of the hypocretin system, suggesting ongoing inhibition by endo
292 of vestibular motor functions by the orexin (hypocretin) system in the perifornical/LH area through t
296 n the PVN during withdrawal was dependent on hypocretin transmission through Hcrtr-1 activation.
297 tates of hyperarousal that are influenced by hypocretin transmission throughout hypothalamic, extende
298 in-releasing factor, norepinephrine, orexin [hypocretin], vasopressin, dynorphin) and brain antistres
300 eurons containing orexin (ORX, also known as hypocretin), which have a crucial role in arousal, vigil
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。